Dear Editor:

We thank Straatmann and Vehaskari [1] for correcting any misrepresentation of their work [2, 3]. Their data strongly support the use of plasmapheresis to treat recurrent FSGS. Hopefully, a randomized clinical trial can be implemented to address this important problem.